FIM
ANGO icon

Freedom Investment Management’s AngioDynamics ANGO Stock Holding History

Freedom Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,136
Closed -$318K – 686
2019
Q2 		$318K Buy
+16,136
New +$329K 0.03% 505
2018
Q3 		– Sell
-20,020
Closed -$445K – 904
2018
Q2 		$445K Sell
20,020
-3,973
-17% -$81.2K 0.03% 601
2018
Q1 		$414K Buy
+23,993
New +$400K 0.02% 717

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Freedom Investment Management's ANGO Position: Q3 2019 in Review

Freedom Investment Management sold out of AngioDynamics (ANGO) in Q3 2019, closing a stake of 16,136 shares — an estimated $318K sold.

Freedom Investment Management first reported a position in ANGO in Q1 2018 and held it in 3 quarters. The position peaked at $445K in Q2 2018. 173 funds tracked by Wall St. Rank hold ANGO as of Q3 2019.

  • Freedom Investment Management reported no remaining AngioDynamics position as of Q3 2019 after selling out during the quarter.
  • Freedom Investment Management sold 16,136 AngioDynamics shares in Q3 2019, an estimated $318K.
  • Freedom Investment Management first reported a position in AngioDynamics in Q1 2018 and held it in 3 quarters.
  • Freedom Investment Management's AngioDynamics position peaked at $445K in Q2 2018.
  • 173 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2019.

Based on Freedom Investment Management's 13F filing for Q3 2019, filed 5 Nov 2019.